Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.5%
    Check dated 2024-09-11T08:31:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.6%
    Check dated 2024-09-04T05:34:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-08-28T02:58:36.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-08-21T00:57:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2.
    Difference
    0.6%
    Check dated 2024-08-14T00:04:13.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-07-29T21:36:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.